본문으로 건너뛰기
← 뒤로

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases.

1/5 보강
Biomedicines 📖 저널 OA 100% 2021: 1/1 OA 2022: 22/22 OA 2023: 20/20 OA 2024: 55/55 OA 2025: 152/152 OA 2026: 94/94 OA 2021~2026 2024 Vol.12(3)
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: lung metastases (DTC-LM) undergoing radioiodine therapy (RAI) after thyroid surgery
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Anaplastic thyroid cancer (ATC), stage IV, and lung metastases associated with other metastases were identified as risk factors for OS and TCSS in TCLM patients. RAI therapy significantly enhances survival in DTC-LM patients followed by primary site surgery under the age of 55, PTC patients, and those with single organ metastases at lung.

Zhang S, Zhu M, Zhang H, Liu H, Fan X, Zhang J

📝 환자 설명용 한 줄

Lung metastasis substantially influences the survival of thyroid cancer (TC) patients.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 추적기간 59 months

이 논문을 인용하기

↓ .bib ↓ .ris
APA Zhang S, Zhu M, et al. (2024). The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases.. Biomedicines, 12(3). https://doi.org/10.3390/biomedicines12030532
MLA Zhang S, et al.. "The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases.." Biomedicines, vol. 12, no. 3, 2024.
PMID 38540145 ↗

Abstract

Lung metastasis substantially influences the survival of thyroid cancer (TC) patients. This study sought to investigate factors impacting the survival of differentiated thyroid cancer patients with lung metastases (DTC-LM) undergoing radioiodine therapy (RAI) after thyroid surgery. The retrospective study encompassed 609 TC patients with lung metastases. Survival outcomes-specifically, overall survival (OS) and thyroid cancer-specific survival (TCSS)-were examined through both univariate and multivariate Cox regression analyses. Radioiodine therapy (RAI)'s impact on DTC-LM patient survival was further assessed with the Kaplan-Meier survival curve. Of the 609 TC patients with lung metastases, 434 (71.3%) were found to have undergone thyroid surgery after a median follow-up of 59 months. Anaplastic thyroid cancer (ATC), stage IV, and lung metastases associated with other metastases were identified as risk factors for OS and TCSS in TCLM patients. RAI therapy significantly enhances survival in DTC-LM patients followed by primary site surgery under the age of 55, PTC patients, and those with single organ metastases at lung.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기